NovelStem International Corp.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NSTM research report →
Companywww.novelstem.com
NovelStem International Corp. focuses on developing and commercialization of diagnostic technology for cancer treatments and the potential to reduce resistance to chemotherapy. The company was formerly known as Hollywood Media Corp.
- CEO
- Jan H. Loeb
- IPO
- 1993
- HQ
- Boca Raton, FL, US
Price Chart
Valuation
- Market Cap
- $493.32K
- P/E
- 0.19
- P/S
- 0.00
- P/B
- -0.24
- EV/EBITDA
- 0.80
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -124.80%
- ROIC
- -662.14%
Growth & Income
- Revenue
- $0 · -100.00%
- Net Income
- $2.38M · 173.61%
- EPS
- $0.05 · 172.57%
- Op Income
- $-238,755
- FCF YoY
- 38.36%
Performance & Tape
- 52W High
- $0.04
- 52W Low
- $0.01
- 50D MA
- $0.01
- 200D MA
- $0.02
- Beta
- 2.65
- Avg Volume
- 6.85K
Get TickerSpark's AI analysis on NSTM
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our NSTM Coverage
We haven't published any research on NSTM yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate NSTM Report →